We are live on
!
Find out more
TCP
Tyndall Capital Partners Portfolio holdings
AUM
$452K
1-Year Est. Return
26.52%
This Fund
S&P 500
This Quarter
Est. Return
-16.99%
1 Year Est. Return
+26.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$505K
AUM Growth
–
Cap. Flow
+$533K
Cap. Flow
% of AUM
105.42%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cyclerion Therapeutics
CYCN
|
+$533K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
CCM
HIP
BPWM
NP
CP
AI
CAWM
ADIM
Tyndall Capital Partners's Q3 2023 Portfolio in Review
As of Q3 2023, Tyndall Capital Partners held 1 position worth $505K. Its ten largest holdings account for 100% of the portfolio.
Tyndall Capital Partners deployed $533K of net new capital in Q3 2023, opening 1 new position. Its largest new stake was Cyclerion Therapeutics: 147,712 shares worth $505K.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Tyndall Capital Partners's largest Q3 2023 buy was Cyclerion Therapeutics: 147,712 shares worth $505K.
- Tyndall Capital Partners's ten largest holdings make up 100% of its $505K portfolio in Q3 2023.
- Tyndall Capital Partners opened 1 new position and closed 0 in Q3 2023.
Based on Tyndall Capital Partners's 13F filing for Q3 2023, filed 14 Nov 2023.